Skip to main content
Alvotech Holdings S.A logo

Alvotech Holdings S.A — Investor Relations & Filings

Ticker · ALVO ISIN · LU2458332611 LEI · 222100DCZBOWV5DZ8372 LU Manufacturing
Filings indexed 924 across all filing types
Latest filing 2026-06-03 Declaration of Voting R…
Country LU Luxembourg
Listing LU ALVO

About Alvotech Holdings S.A

https://www.alvotech.com/

Alvotech is a biotechnology company that specializes in the development and manufacturing of biosimilar medicines for patients worldwide. The company's mission is to improve lives by expanding access to high-quality, affordable biologic medicines. Alvotech operates a fully integrated, end-to-end platform that encompasses the entire process from cell line development through to fill and finish manufacturing. This vertically integrated approach provides control over scale, speed, and quality. For commercialization and registration in global markets, Alvotech leverages strategic partnerships, allowing it to maintain a singular focus on its core development and manufacturing expertise. The company's product pipeline targets various therapeutic areas, including autoimmune and eye disorders.

Recent filings

Filing Released Lang Actions
Niðurstaða aðalfundar Alvotech árið 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an official announcement of the outcome of the Annual General Meeting (AGM) of Alvotech on June 3, 2026, stating that all proposals were approved and that detailed voting results will be published. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-06-03 Icelandic
Main Results of 2026 Annual and Extraordinary General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “Main Results of 2026 Annual and Extraordinary General Meeting” and provides the outcome of shareholders’ votes on draft resolutions at the AGM. It announces the voting results rather than the full meeting materials or minutes. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-06-03 Yoruba
Alvotech tekur þátt í þremur fjárfestaráðstefnum í Bandaríkjunum í júní
Regulatory Filings Classification · 82% confidence The document is a press release announcing Alvotech’s participation in three investor conferences (Jefferies, Goldman Sachs, UBS) with dates and event details. It does not contain financial statements, earnings highlights, or published report materials, nor does it announce the release of a report or proxy. It is an event/investor relations announcement that does not fit a more specific category, so it falls under the general regulatory or miscellaneous announcements category (RNS).
2026-06-02 Icelandic
Alvotech to present at upcoming investor conferences in June
Regulatory Filings Classification · 75% confidence The document is a press release announcing that company executives will participate in upcoming investor conferences and provides webcast details. It does not include actual financial data or investor slide decks, nor is it an AGM presentation or regulatory report publication. It is a general corporate announcement that does not fit other specific categories, so it falls under the fallback regulatory filings category (RNS).
2026-06-02 English
Alvotech og Íslandsbanki endurnýja samning um viðskiptavakt með bréf félagsins í Kauphöllinni
Regulatory Filings Classification · 85% confidence The document is a press release announcing the renewal of a market-making agreement between Alvotech and Íslandsbanki on Nasdaq Iceland. It does not present actual financial results, issue new shares, discuss dividends, or constitute a formal financial report. It is a general regulatory announcement regarding a contractual arrangement and thus falls into the fallback “Regulatory Filings” category.
2026-06-01 Icelandic
Alvotech and Islandsbanki renew Market Making Agreement for ALVO Shares Trading on Nasdaq Iceland
Regulatory Filings Classification · 91% confidence The document is a press release announcing the renewal of a market making agreement between Alvotech and Islandsbanki. It does not present financial statements, election or voting details, M&A transaction, fundraising or capital change, or any specific regulatory form. It is a generic corporate announcement, falling under the fallback category for miscellaneous regulatory filings.
2026-06-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.